Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel murine model developed to test CNS-penetrant BTK inhibitors

Feb. 28, 2022

BAFF biomarker tied to severity of allergic rhinitis

Feb. 28, 2022

Bryostatin-1 promotes regenerative phenotype within microglia and CNS macrophages

Feb. 28, 2022

Type II interferon restricts severity of NMO in a new preclinical model

Feb. 28, 2022

STING signaling in beta cells maintains glucose homeostasis

Feb. 28, 2022

Mouse model of SARS-CoV-2 infection shows COVID-19-like disease is dependent on ACE2

Feb. 28, 2022

China Hinye Pharmaceutical presents prodrugs of the active metabolite of clopidogrel

Feb. 28, 2022

Apoptosis regulator Bcl-2 inhibitors discovered at Beijing Innocare Medical Technology

Feb. 28, 2022

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent TLR7/8/9 antagonists

Feb. 28, 2022

Shanghai Zheye Biotechnology describes new anticancer compounds

Feb. 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...